Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer

Hormone Receptor Status Rather Than HER2 Status Is Significantly Associated With Increased Ki-67 and p53 Expression in Triple-Negative Breast Carcinomas, and High Expression of Ki-67 but Not p53 Is Significantly Associated With Axillary Nodal Metastasis in Triple-Negative and High-Grade Non–Triple-Negative Breast Carcinomas

(2011) Jeong S. Han et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53

(2011) E K A Millar et al.   BRITISH JOURNAL OF CANCER

Comparable Survival Between pN0 Breast Cancer Patients Undergoing Sentinel Node Biopsy and Extensive Axillary Dissection: A Report From the Korean Breast Cancer Society

(2010) Hyeong-Gon Moon et al.   JOURNAL OF CLINICAL ONCOLOGY

Accumulation of p53 determined by immunohistochemistry as a prognostic marker in node negative breast cancer; analysis according to st gallen consensus and intrinsic subtypes

(2010) So-Youn Jung et al.   JOURNAL OF SURGICAL ONCOLOGY

Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation

(2010) S. D. Konduri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer

(2009) Wonshik Han et al.   BREAST CANCER RESEARCH AND TREATMENT

p53 as a Specific Prognostic Factor in Triple-negative Breast Cancer

(2009) B. J. Chae et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes

(2008) F.-C. Bidard et al.   ANNALS OF ONCOLOGY

Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17

(2008) Hyman B. Muss et al.   JOURNAL OF CLINICAL ONCOLOGY

Transcriptional control of human p53-regulated genes

(2008) Todd Riley et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY